NI
TVRD

Numeric Investors’s Tvardi Therapeutics TVRD Stock Holding History

Numeric Investors’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,406
Closed -$315K – 1199
2016
Q1 		$315K Buy
1,406
+791
+129% +$236K ﹤0.01% 849
2015
Q4 		$374K Sell
615
-401
-39% -$220K ﹤0.01% 804
2015
Q3 		$523K Buy
+1,016
New +$680K 0.01% 689
2014
Q4 		– Sell
-843
Closed -$255K – 993
2014
Q3 		$255K Buy
+843
New +$346K ﹤0.01% 714

Other funds holding TVRD

TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Numeric Investors's TVRD Position: Q2 2016 in Review

Numeric Investors sold out of Tvardi Therapeutics (TVRD) in Q2 2016, closing a stake of 1,406 shares — an estimated $315K sold.

Numeric Investors first reported a position in TVRD in Q3 2014 and held it in 4 quarters. The position peaked at $523K in Q3 2015. 70 funds tracked by Wall St. Rank hold TVRD as of Q2 2016.

  • Numeric Investors reported no remaining Tvardi Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Numeric Investors sold 1,406 Tvardi Therapeutics shares in Q2 2016, an estimated $315K.
  • Numeric Investors first reported a position in Tvardi Therapeutics in Q3 2014 and held it in 4 quarters.
  • Numeric Investors's Tvardi Therapeutics position peaked at $523K in Q3 2015.
  • 70 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2016.

Based on Numeric Investors's 13F filing for Q2 2016, filed 16 Aug 2016.